GIDHX
Price
$7.46
Change
-$0.09 (-1.19%)
Updated
Sep 20 closing price
VTSNX
Price
$135.52
Change
-$1.58 (-1.15%)
Updated
Sep 20 closing price
Ad is loading...

GIDHX vs VTSNX

Header iconGIDHX vs VTSNX Comparison
Open Charts GIDHX vs VTSNXBanner chart's image
Goldman Sachs Intl Eq Div & Prem Instl
Price$7.46
Change-$0.09 (-1.19%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$135.52
Change-$1.58 (-1.15%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GIDHX vs VTSNX Comparison Chart
Loading...
VS
GIDHX vs. VTSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GIDHX is a StrongBuy and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 453B vs. GIDHX (164M). GIDHX pays higher dividends than VTSNX: GIDHX (3.49) vs VTSNX (3.29). GIDHX was incepted earlier than VTSNX: GIDHX (17 years) vs VTSNX (14 years). GIDHX is a more actively managed with annual turnover of: 18.00 vs. VTSNX (4.00). GIDHX has a lower initial minimum investment than VTSNX: GIDHX (1000000) vs VTSNX (5000000). VTSNX annual gain was more profitable for investors over the last year : 14.36 vs. GIDHX (13.38). GIDHX (25.08) and VTSNX (24.19) have equivalent 5 years return.
GIDHXVTSNXGIDHX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years14 years-
Gain YTD5.8678.24571%
Front LoadN/AN/A-
Min. Initial Investment1000000500000020%
Min. Initial Investment IRAN/AN/A-
Net Assets164M453B0%
Annual Yield % from dividends3.493.29106%
Returns for 1 year13.3814.3693%
Returns for 3 years11.99-1.37-874%
Returns for 5 years25.0824.19104%
Returns for 10 years22.4529.0577%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAP180.425.19
+2.96%
Credicorp Ltd
ATXS11.610.11
+0.96%
Astria Therapeutics
LGIH120.53-0.74
-0.61%
LGI Homes
ACHV4.40-0.08
-1.79%
Achieve Life Sciences
UPC0.36-0.04
-9.87%
Universe Pharmaceuticals